CLINICAL PHARMACOKINETICS IN DRUG SAFETY EVALUATION

被引:0
|
作者
PARKE, DV
机构
来源
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 1994年 / 22卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:207 / 209
页数:3
相关论文
共 50 条
  • [41] Drug Safety Evaluation in China
    Lisha Li
    Jia Yin
    Current Allergy and Asthma Reports, 2019, 19
  • [42] Drug safety evaluation of desogestrel
    Scala, Carolina
    Maggiore, Umberto Leone Roberti
    Remorgida, Valentino
    Venturini, Pier Luigi
    Ferrero, Simone
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (03) : 433 - 444
  • [43] Drug Safety Evaluation in China
    Li, Lisha
    Yin, Jia
    CURRENT ALLERGY AND ASTHMA REPORTS, 2019, 19 (09)
  • [44] Drug safety evaluation of rosuvastatin
    Toth, Peter P.
    Dayspring, Thomas D.
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 969 - 986
  • [45] Drug safety evaluation of exemestane
    Lintermans, Anneleen
    Neven, Patrick
    Paridaens, Robert
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (03) : 473 - 487
  • [46] Drug safety evaluation of pregabalin
    Toth, Cory
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 487 - 502
  • [47] Drug safety evaluation of rotigotine
    Sprenger, Fabienne Stephanie
    Seppi, Klaus
    Poewe, Werner
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 503 - 512
  • [48] Drug safety evaluation of defibrotide
    Richardson, Paul G.
    Corbacioglu, Selim
    Ho, Vincent Trien-Vinh
    Kernan, Nancy A.
    Lehmann, Leslie
    Maguire, Craig
    Maglio, Michelle
    Hoyle, Margaret
    Sardella, Marco
    Giralt, Sergio
    Holler, Ernst
    Carreras, Enric
    Niederwieser, Dietger
    Soiffer, Robert
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (01) : 123 - 136
  • [49] Drug safety evaluation of amlodipine
    Derosa, G.
    Maffioli, P.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2018, 13 (03) : 177 - 177
  • [50] A drug safety evaluation of valsartan
    Fogari, Roberto
    Zoppi, Annalisa
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (02) : 295 - 303